German Low Grade Lymphoma Study Group Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2000
NCT00016887
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

German Low Grade Lymphoma Study Group (GLSG/OSHO)